These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 28067045)
21. Methylone pre-exposure differentially impacts the aversive effects of MDPV and MDMA in male and female Sprague-Dawley rats: Implications for abuse vulnerability. Manke HN; Nelson KH; Huang S; Bailey JM; Bowman SK; Jones RA; Cerveny SE; Rice KC; Riley AL Pharmacol Biochem Behav; 2022 Oct; 220():173470. PubMed ID: 36206863 [TBL] [Abstract][Full Text] [Related]
22. Dopaminergic Effects of Major Bath Salt Constituents 3,4-Methylenedioxypyrovalerone (MDPV), Mephedrone, and Methylone Are Enhanced Following Co-exposure. Allen SA; Tran LH; Oakes HV; Brown RW; Pond BB Neurotox Res; 2019 Jul; 36(1):132-143. PubMed ID: 30879275 [TBL] [Abstract][Full Text] [Related]
23. Effects of social interaction and warm ambient temperature on brain hyperthermia induced by the designer drugs methylone and MDPV. Kiyatkin EA; Kim AH; Wakabayashi KT; Baumann MH; Shaham Y Neuropsychopharmacology; 2015 Jan; 40(2):436-45. PubMed ID: 25074640 [TBL] [Abstract][Full Text] [Related]
24. Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats. Berquist MD; Traxler HK; Mahler AM; Baker LE Drug Alcohol Depend; 2016 Jul; 164():128-134. PubMed ID: 27181413 [TBL] [Abstract][Full Text] [Related]
25. Quantification of Synthetic Cathinones in Rat Brain Using HILIC-ESI-MS/MS. Peters JR; Keasling R; Brown SD; Pond BB J Anal Toxicol; 2016 Nov; 40(9):718-725. PubMed ID: 27474358 [TBL] [Abstract][Full Text] [Related]
26. Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats. Bonano JS; Glennon RA; De Felice LJ; Banks ML; Negus SS Psychopharmacology (Berl); 2014 Jan; 231(1):199-207. PubMed ID: 23949206 [TBL] [Abstract][Full Text] [Related]
27. Crystallographic investigations of select cathinones: emerging illicit street drugs known as `bath salts'. Wood MR; Lalancette RA; Bernal I Acta Crystallogr C Struct Chem; 2015 Jan; 71(Pt 1):32-8. PubMed ID: 25567572 [TBL] [Abstract][Full Text] [Related]
28. Behavioral pharmacology of designer cathinones: a review of the preclinical literature. Gregg RA; Rawls SM Life Sci; 2014 Feb; 97(1):27-30. PubMed ID: 24231450 [TBL] [Abstract][Full Text] [Related]
29. Discriminative-Stimulus Effects of Synthetic Cathinones in Squirrel Monkeys. Wakeford AGP; Sherwood AM; Prisinzano TE; Bergman J; Kohut SJ; Paronis CA Int J Neuropsychopharmacol; 2021 Aug; 24(8):656-665. PubMed ID: 33909067 [TBL] [Abstract][Full Text] [Related]
30. MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment. Kiyatkin EA; Ren SE Curr Top Behav Neurosci; 2017; 32():183-207. PubMed ID: 27677782 [TBL] [Abstract][Full Text] [Related]
31. Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption. Blum K; Foster Olive M; Wang KK; Febo M; Borsten J; Giordano J; Hauser M; Gold MS Med Hypotheses; 2013 Sep; 81(3):450-5. PubMed ID: 23845561 [TBL] [Abstract][Full Text] [Related]
32. Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice. Karlsson L; Andersson M; Kronstrand R; Kugelberg FC Basic Clin Pharmacol Toxicol; 2014 Nov; 115(5):411-6. PubMed ID: 24739011 [TBL] [Abstract][Full Text] [Related]
33. Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Schindler CW; Thorndike EB; Goldberg SR; Lehner KR; Cozzi NV; Brandt SD; Baumann MH Psychopharmacology (Berl); 2016 May; 233(10):1981-90. PubMed ID: 26319160 [TBL] [Abstract][Full Text] [Related]
34. Distribution of methylone in four postmortem cases. Cawrse BM; Levine B; Jufer RA; Fowler DR; Vorce SP; Dickson AJ; Holler JM J Anal Toxicol; 2012 Jul; 36(6):434-9. PubMed ID: 22582221 [TBL] [Abstract][Full Text] [Related]
35. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters. Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092 [TBL] [Abstract][Full Text] [Related]
36. The pharmacology and neurotoxicology of synthetic cathinones. Angoa-Perez M; Kuhn DM Adv Pharmacol; 2024; 99():61-82. PubMed ID: 38467489 [TBL] [Abstract][Full Text] [Related]
37. The pharmacokinetic profile of synthetic cathinones in a pregnancy model. Strange LG; Kochelek K; Keasling R; Brown SD; Pond BB Neurotoxicol Teratol; 2017 Sep; 63():9-13. PubMed ID: 28811141 [TBL] [Abstract][Full Text] [Related]
38. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture. Harvey EL; Baker LE Psychopharmacology (Berl); 2016 Feb; 233(4):673-80. PubMed ID: 26558618 [TBL] [Abstract][Full Text] [Related]
39. Apoptotic effects of the 'designer drug' methylenedioxypyrovalerone (MDPV) on the neonatal mouse brain. Adám A; Gerecsei LI; Lepesi N; Csillag A Neurotoxicology; 2014 Sep; 44():231-6. PubMed ID: 25063209 [TBL] [Abstract][Full Text] [Related]
40. Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats. Huang PK; Aarde SM; Angrish D; Houseknecht KL; Dickerson TJ; Taffe MA Drug Alcohol Depend; 2012 Nov; 126(1-2):168-75. PubMed ID: 22664136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]